Florida Cancer Specialists is bringing their community oncology expertise to North Port, FL with a new cancer center.
Fort Myers, Fla., Oct. 11, 2021 – Florida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art North Port Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders. Located at 1390 Grand Venture Drive, North Port, FL. 34286, it replaces the FCS clinic at 3085 Bobcat Village Center Road in North Port.
In nearly 20,000 square feet of space, the FCS North Port Cancer Center includes 16 exam rooms, 45 chemotherapy infusion chairs and PET/CT scan technology, as well as laboratory, oral oncolytic specialty pharmacy and care management services.
“FCS is dedicated to providing patients with exceptional cancer care close to home and we are proud to keep pace with expanded services for this rapidly growing community in south Sarasota County,” said FCS Chief Executive Officer Nathan H. Walcker. “Our new cancer center in North Port features a patient-centered environment, thoughtfully designed to enhance patient comfort and convenience.”
FCS President and Managing Physician Lucio Gordan, MD said, “In addition to accessing a variety of personalized services and the most advanced treatments and therapies all under one roof, patients will have expanded opportunities to participate in clinical trials of the most promising new cancer treatments.”
FCS Board-certified medical oncologists Alexander Glick, MD, Christopher Lobo, MD, Ivor Percent, MD, Arsh Singh, MD, Stephen Vara, MD and Vance Wright-Browne, MD are providing care to patients at the FCS North Port Cancer Center.
About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.